secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantheus Holdings, Inc. (LNTH)
CIK:        0001521036
Form:       8-K
Filed at:   2023-08-18T23:59:59+00:00
Accession:  0001193125-23-215459
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lantheus discontinues AZEDRA production; winds down Somerset, NJ site
---------------------------------------------------------------------

- Progenics Pharmaceuticals subsidiary to stop manufacturing and promoting AZEDRA.
- Limited usage and fixed costs made continued production untenable.
- Goal to supply current patients through Q1 2024 to complete treatment.
- Somerset, NJ manufacturing site being wound down.
- No financial impact or restructuring charges disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1521036/000119312523215459/0001193125-23-215459-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1521036/000119312523215459/d300211d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-215459

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer